105 related articles for article (PubMed ID: 30366103)
21. Clinical indications and results after chest wall resection for recurrent mesothelioma.
Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
[TBL] [Abstract][Full Text] [Related]
22. Extrapleural pneumonectomy or supportive care: treatment of malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1040-5. PubMed ID: 21388982
[TBL] [Abstract][Full Text] [Related]
23. [Long-term prognostic analysis of patients with malignant pleural mesothelioma].
Cao KJ; Cui NJ
Ai Zheng; 2005 Jan; 24(1):72-5. PubMed ID: 15642204
[TBL] [Abstract][Full Text] [Related]
24. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review.
Dawson AG; Kutywayo K; Mohammed SB; Fennell DA; Nakas A
Thorax; 2023 Apr; 78(4):409-417. PubMed ID: 35410957
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and therapeutic strategy in malignant pleural mesothelioma.
Branscheid D; Krysa S; Bauer E; Bülzebruck H; Schirren J
Eur J Cardiothorac Surg; 1991; 5(9):466-72; discussion 473. PubMed ID: 1931091
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells (CTCs) in malignant pleural mesothelioma (MPM).
Yoneda K; Tanaka F; Kondo N; Hashimoto M; Takuwa T; Matsumoto S; Okumura Y; Tsubota N; Sato A; Tsujimura T; Kuribayashi K; Fukuoka K; Tabata C; Nakano T; Hasegawa S
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S472-80. PubMed ID: 24306661
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
[TBL] [Abstract][Full Text] [Related]
29. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
[TBL] [Abstract][Full Text] [Related]
30. [57 Years of Age Woman with Continuous Thoracic Pain, Accompanied by Cough, Fever, Progressive Dyspnea and Weight Loss].
Salazar-Flores M; Ondarza-Aguilera C; Torre-Bouscoulet L; Alva-López LF; Ortega-Estrada J
Gac Med Mex; 2003; 139(3):265-9. PubMed ID: 12872419
[No Abstract] [Full Text] [Related]
31. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
[TBL] [Abstract][Full Text] [Related]
32. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma.
Burt BM; Rodig SJ; Tilleman TR; Elbardissi AW; Bueno R; Sugarbaker DJ
Cancer; 2011 Nov; 117(22):5234-44. PubMed ID: 21523763
[TBL] [Abstract][Full Text] [Related]
33. Second surgery for recurrence of malignant pleural mesothelioma after extrapleural pneumonectomy.
Politi L; Borzellino G
Ann Thorac Surg; 2010 Jan; 89(1):207-10. PubMed ID: 20103236
[TBL] [Abstract][Full Text] [Related]
34. Is serum thioredoxin-1 a useful clinical marker for malignant pleural mesothelioma?
Maeda R; Tabata C; Tabata R; Eguchi R; Fujimori Y; Nakano T
Antioxid Redox Signal; 2011 Aug; 15(3):685-9. PubMed ID: 21375472
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Score of Long-Term Survival After Surgery for Malignant Pleural Mesothelioma: A Multicenter Analysis.
Leuzzi G; Rea F; Spaggiari L; Marulli G; Sperduti I; Alessandrini G; Casiraghi M; Bovolato P; Pariscenti G; Alloisio M; Infante M; Pagan V; Fontana P; Oliaro A; Ruffini E; Ratto GB; Leoncini G; Sacco R; Mucilli F; Facciolo F
Ann Thorac Surg; 2015 Sep; 100(3):890-7. PubMed ID: 26163973
[TBL] [Abstract][Full Text] [Related]
36. Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis.
Baud M; Strano S; Dechartres A; Jouni R; Triponez F; Chouaid C; Forgez P; Damotte D; Roche N; Régnard JF; Alifano M
J Thorac Cardiovasc Surg; 2013 May; 145(5):1305-11. PubMed ID: 23072703
[TBL] [Abstract][Full Text] [Related]
37. Predicting survival in malignant pleural mesothelioma using routine clinical and laboratory characteristics.
Gunatilake S; Lodge D; Neville D; Jones T; Fogg C; Bassett P; Begum S; Kerley S; Marshall L; Glaysher S; Elliott S; Stores R; Bishop L; Chauhan A
BMJ Open Respir Res; 2021 Jan; 8(1):. PubMed ID: 33414260
[TBL] [Abstract][Full Text] [Related]
38. Cytoreductive surgery combined with intraoperative hyperthermic intrathoracic chemotherapy for stage I malignant pleural mesothelioma.
van Ruth S; Baas P; Haas RL; Rutgers EJ; Verwaal VJ; Zoetmulder FA
Ann Surg Oncol; 2003 Mar; 10(2):176-82. PubMed ID: 12620914
[TBL] [Abstract][Full Text] [Related]
39. Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
Cao C; Krog Andvik SK; Yan TD; Kennedy C; Bannon PG; McCaughan BC
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):754-7. PubMed ID: 21303872
[TBL] [Abstract][Full Text] [Related]
40. Pleural thickness after neoadjuvant chemotherapy is a prognostic factor in malignant pleural mesothelioma.
Hashimoto M; Takeuchi J; Takuwa T; Kuroda A; Nakamura A; Nakamichi T; Matsumoto S; Kondo N; Nakano T; Morimoto T; Hasegawa S
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):404-413. PubMed ID: 30557956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]